# ATG-008 Combined With Toripalimab in Advanced Solid Tumors

> **NCT04337463** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Sichuan University** · enrollment: 60 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** ATG-008
- **DRUG:** Toripalimab

## Key facts

- **NCT ID:** NCT04337463
- **Lead sponsor:** Sichuan University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-23
- **Primary completion:** 2022-05-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04337463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04337463, "ATG-008 Combined With Toripalimab in Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04337463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*